A Antonelli, C Ferri, P Fallahi, A Pampana, SM … - Diabetes Care, 2005 - Am Diabetes Assoc An increased prevalence of type 2 diabetes and impaired glucose tolerance has
been consistently found in liver cirrhosis from any cause (1–3). Less clear is
whether hepatitis C virus (HCV) infection is associated with type 2 ... Cited by 45 - Related articles - BL Direct - All 6 versions
A Lecube, C Hernández, J Genescà, R Simó - Diabetes Care, 2006 - Am Diabetes Assoc Hepatitis C virus (HCV) infection is a major cause of chronic liver disease,
affecting ∼3% of the world's population (1,2). The disease is characterized by
silent onset in most infected individuals (3), and recent studies indicate ... Cited by 29 - Related articles - BL Direct - All 8 versions
G Marchesini, G Forlani, E Bugianesi - Annals of Medicine, 2005 - informahealthcare.com The association of metabolic disorders with liver disease is receiving
increasing attention in the gastroenterological community. Cohort studies have
shown that advanced liver disease may stem from metabolic disorders, via ... Cited by 20 - Related articles - BL Direct - All 7 versions
KB Aborsangaya, I Dembinski, S Khatkar, MP … - Hepatology, 2007 - interscience.wiley.com The host immune response is a critical determinant in viral infection outcome.
Epidemiological studies indicate that North American indigenous peoples are more
resistant to chronic HCV infection than other populations. Due to the ... Cited by 13 - Related articles - BL Direct - All 3 versions
C Ferri, A Antonelli, MT Mascia, M Sebastiani, … - Digestive and Liver Disease, 2007 - Elsevier Hepatitis C virus (HCV) chronic infection may be associated with a great number
of both hepatic and extrahepatic manifestations. HCV lymphotropism is
responsible for poly-oligoclonal B-lymphocyte expansion, which is the ... Cited by 13 - Related articles - All 9 versions
A Lonardo, P Loria, N Carulli - Internal and Emergency Medicine, 2008 - Springer Abstract Although not associated with the metabolic syndrome, HCV is linked with
impaired insulin signalling, insulin resistance, hypocholesterolemia and
steatosis which represent a distinct HCV-associated dysmetabolic syn- ... Cited by 8 - Related articles - BL Direct - All 2 versions
Y Doi, M Kubo, K Yonemoto, T Ninomiya, M … - Obesity, 2007 - nature.com * The costs of publication of this article were defrayed, in part, by the
payment of page charges. This article must, therefore, be hereby marked
"advertisement" in accordance with 18 USC Section 1734 solely to indicate ... Cited by 7 - Related articles
- ►nih.gov [PDF] AS Neumeister, LVE Pilcher, JM Erickson, LL … - Journal of the National medical Association, 2007 - pubmedcentral.nih.gov Financial support: This study was supported by a Minority Health Education and
Research Office grant of the University of Nebraska Medical Center and a
Research Support Fund grant of The Nebraska Medical Center. Dr. Larsen is ... Cited by 5 - Related articles - BL Direct - All 3 versions
JD Rempel, KB Aborsangaya, MP Alphonse, … - Journal of Viral Hepatitis, 2009 - umanitoba.ca SUMMARY. North American Aboriginals have an enhanced propensity to clear HCV
infection. Interferon (IFN)-a is a crit- ical agent in the clearance of
hepatitis C virus (HCV) and other viruses; therefore the influence of ... Cited by 1 - Related articles - View as HTML - All 4 versions
JD Scott, N Garland, 2008 - pubmedcentral.nih.gov A structured literature review was performed to detail the frequency and
etiology of chronic liver disease (CLD) in Aboriginal North Americans. CLD
affects Aboriginal North Americans disproportionately and is now one of the ... Cited by 1 - Related articles - All 8 versions
